What is Maolac?
Maolac operates at the intersection of biotechnology and nutritional science, specializing in the development of advanced colostrum-based biofunctional proteins. By leveraging the unique properties of bovine colostrum to mimic the benefits of human breast milk, the company has engineered proprietary solutions such as Super Colostrum and Maolactin. These products are specifically formulated to enhance gut health, facilitate muscle recovery, and support systemic wellness. With a focus on heat-stable, versatile delivery formats like gummies and powders, Maolac is strategically positioned to disrupt the functional food market, catering to high-performance athletes, the aging population, and health-conscious consumers seeking evidence-based nutritional interventions.
How much funding has Maolac raised?
Maolac has raised a total of $3.2M across 1 funding round:
Angel/Seed
$3.2M
Angel/Seed (2022): $3.2M with participation from The Food Tech Lab, OurCrowd, and The Kitchen FoodTech H
Key Investors in Maolac
The Food Tech Lab
An innovation hub and investment entity focused on accelerating the development of disruptive technologies within the global food and agriculture supply chain.
OurCrowd
A prominent global venture investment platform that provides accredited investors and institutions with access to early-stage startups and venture funds.
The Kitchen FoodTech H
A specialized food-tech incubator and investment firm dedicated to fostering sustainable and innovative solutions for the future of food production.
What's next for Maolac?
With this major strategic investment, Maolac is poised to scale its manufacturing capabilities and expand its footprint in the functional food and supplement industry. The company's roadmap likely includes deepening its clinical research portfolio to substantiate health claims, which is essential for securing partnerships with major global food and beverage conglomerates. By focusing on the scalability of its heat-stable protein formulations, Maolac aims to transition from a niche biotech innovator to a mainstream supplier of high-efficacy nutritional ingredients. Future growth will be driven by the commercialization of its core product lines and the potential for licensing its proprietary protein technology to broader consumer packaged goods manufacturers.
See full Maolac company page
